Enanta Pharmaceuticals ENTA
NASDAQ ENTA
$12.70 -0.14 (-1.05%)
As of: Oct 2, 2026 · 9:41 AM EDT

Enanta Pharmaceuticals (ENTA) Accumulated Expenses (2012 - 2026)

Updated

Enanta Pharmaceuticals (ENTA) recorded Accumulated Expenses of $10.18 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), down 6.2% from $10.85 million a year earlier but up 48.5% from the prior quarter.

Analysis

Enanta Pharmaceuticals (ENTA) Accumulated Expenses (2012 - 2026) Analysis & Trends

At the end of FY2025 (ended Sep 30, 2025), Enanta Pharmaceuticals reported Accumulated Expenses of $12.75 million, down 5.9% from FY2024.

  • Annual Accumulated Expenses has declined for four straight fiscal years, with a five-year compound annual growth rate of -2.1% (FY2020 to FY2025).
  • Across earlier fiscal years, Accumulated Expenses came in at $13.55 million in FY2024 (-26.1%), $18.34 million in FY2023 (-12.4%), $20.94 million in FY2022 (-6.7%) and $22.43 million in FY2021 (+58.4%).
  • Quarterly Accumulated Expenses has ranged from $6.86 million in fiscal Q2 2026 to $26.58 million in fiscal Q1 2022 over the past five years.
  • On a year-over-year basis, Accumulated Expenses has declined for 16 consecutive quarters, with an average decline of 16.3% over the last eight quarters.
  • Peak year-over-year performance for Accumulated Expenses in the last five years was growth of 130.3% in fiscal Q1 2022, against a decline of 43.0% in fiscal Q1 2023 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at $6.86 million (Q2 2026), $7.58 million (Q1 2026) and $12.75 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Enanta Pharmaceuticals 383.80 Mn -344.19 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.18 Mn
Mar 31, 2026 6.86 Mn
Dec 31, 2025 7.58 Mn
Sep 30, 2025 12.75 Mn
Jun 30, 2025 10.85 Mn
Mar 31, 2025 8.31 Mn
Dec 31, 2024 10.58 Mn
Sep 30, 2024 13.55 Mn
Jun 30, 2024 12.83 Mn
Mar 31, 2024 10.63 Mn
Dec 31, 2023 11.60 Mn
Sep 30, 2023 18.34 Mn
Jun 30, 2023 18.20 Mn
Mar 31, 2023 15.48 Mn
Dec 31, 2022 15.16 Mn
Sep 30, 2022 20.94 Mn
Jun 30, 2022 19.19 Mn
Mar 31, 2022 21.74 Mn
Dec 31, 2021 26.58 Mn
Sep 30, 2021 22.43 Mn
API Access

Enanta Pharmaceuticals Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ENTA&period=max&api_key=YOUR_API_KEY